I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Llanos-Ackert, J.
23
results:
Search for persons
X
Languages
english (19)
french (2)
Sorted by: Relevance
Sorted by: Year
?
1
TEZEPELUMAB EFFICACY IN PATIENTS WITH SEVERE ASTHMA BY BLOO..:
Wechsler, M.
;
Carr, T.
;
Ponnarambil, S.
...
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S45-S46 , 2023
Link:
https://doi.org/10.1016/..
?
2
TEZEPELUMAB REDUCES ALL KEY INFLAMMATORY BIOMARKER LEVELS I..:
Mathur, S.
;
Jacobs, J.
;
Ponnarambil, S.
...
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S43 , 2023
Link:
https://doi.org/10.1016/..
?
3
RECENT REAL-WORLD BIOLOGIC UTILIZATION AMONG ADULTS WITH SE..:
Soong, W.
;
Panettieri, R.
;
Carr, W.
...
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S44-S45 , 2023
Link:
https://doi.org/10.1016/..
?
4
TEZEPELUMAB REDUCED OCS USE IN OCS-DEPENDENT PATIENTS WITH ..:
Jackson, D.
;
Lugogo, N.
;
Gurnell, M.
...
Annals of Allergy, Asthma & Immunology. 131 (2023) 5 - p. S43 , 2023
Link:
https://doi.org/10.1016/..
?
5
EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLL..:
Jain, N.
;
Llanos-Ackert, J.
;
Ambrose, C.
...
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S36-S37 , 2022
Link:
https://doi.org/10.1016/..
?
6
PATIENT-REPORTED TRIGGER NUMBER IS A STRONG PREDICTOR OF UN..:
Chipps, B.
;
Soong, W.
;
Panettieri, R.
...
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S46-S47 , 2022
Link:
https://doi.org/10.1016/..
?
7
EFFICACY OF BIOLOGICS IN PATIENTS WITH SEVERE ALLERGIC ASTH..:
Bernstein, J.
;
Korn, S.
;
Ambrose, C.
...
Annals of Allergy, Asthma & Immunology. 129 (2022) 5 - p. S3 , 2022
Link:
https://doi.org/10.1016/..
?
8
Efficacité du tézépélumab chez les patients asthmatiques sé..:
Carr, T.
;
Bernstein, J.
;
Cook, B.
...
Revue Française d'Allergologie. 63 (2023) 3 - p. 103596 , 2023
Link:
https://doi.org/10.1016/..
?
9
Effect Of Tezepelumab In Patients With Severe, Uncontrolled..:
Mathur, Sameer
;
Hill, Jennifer
;
Ambrose, Chris
...
Journal of Allergy and Clinical Immunology. 151 (2023) 2 - p. AB17 , 2023
Link:
https://doi.org/10.1016/..
?
10
Effect Of Tezepelumab On Rescue Medication Use And Night-Ti..:
Carr, Warner
;
Ambrose, Chris
;
Hunter, Gillian
...
Journal of Allergy and Clinical Immunology. 151 (2023) 2 - p. AB14 , 2023
Link:
https://doi.org/10.1016/..
?
11
Tezepelumab Reduces Exacerbations Across All Seasons in Pat..:
Hoyte, Flavia
;
Martin, Neil
;
Kmita, Kamil
...
Journal of Allergy and Clinical Immunology. 149 (2022) 2 - p. AB63 , 2022
Link:
https://doi.org/10.1016/..
?
12
Efficacy of Tezepelumab in Patients with Moderate-to-Severe..:
Ambrose, Chris
;
Menzies-Gow, Andrew
;
Cook, Bill
...
Journal of Allergy and Clinical Immunology. 149 (2022) 2 - p. AB16 , 2022
Link:
https://doi.org/10.1016/..
?
13
Tézépélumab réduit les exacerbations quelle que soit la sai..:
Hoyte, F.C.L.
;
Martin, N.
;
Kmita, K.
...
Revue Française d'Allergologie. 62 (2022) 3 - p. 360 , 2022
Link:
https://doi.org/10.1016/..
?
14
Efficacy of Tezepelumab in Patients with Severe, Uncontroll..:
Carr, Tara
;
Bernstein, Jonathan
;
Cook, Bill
...
Journal of Allergy and Clinical Immunology. 149 (2022) 2 - p. AB152 , 2022
Link:
https://doi.org/10.1016/..
?
15
Tezepelumab Treatment Reduced Asthma Symptomatic Days in Ad..:
Carr, Warner
;
Jain, Neal
;
Ambrose, Chris
...
Journal of Allergy and Clinical Immunology. 149 (2022) 2 - p. AB16 , 2022
Link:
https://doi.org/10.1016/..
1-15